源自人类GH分泌的或临床上无功能的垂体腺瘤的原代培养物

Roberto Würth; Alessandra Pattarozzi; Federica Barbieri; Tullio Florio

doi:10.21769/BioProtoc.2790

Improve Research Reproducibility A Bio-protocol resource

提交稿件
订阅
CN
- EN - English
- CN - 中文

Peer-reviewed

Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas

源自人类GH分泌的或临床上无功能的垂体腺瘤的原代培养物

Roberto Würth

Alessandra Pattarozzi

Federica Barbieri

Tullio Florio email

发布: 2018年04月05日第8卷第7期 DOI: 10.21769/BioProtoc.2790 浏览次数: 6819

评审: Oneil G. BhalalaShweta GargJalaj Gupta

下载 PDF

Q&A

引用

Cited by

参见作者原研究论文

The authors used this protocol in:

Cover of Molecular Neurobiology, featuring study using the protocol.

Sep 2017

实验方案合集

Cell Imaging - A Special Collection for Cell Bio 2023

相关实验方案

人婴幼儿血管瘤中干细胞、内皮细胞和周细胞的分离

Lan Huang and Joyce Bischoff

2020年01月20日 4064 阅读

用于人结直肠上皮类器官和类肿瘤的低粘度基质悬浮培养

Tao Tan [...] Oliver M. Sieber

2022年04月20日 3139 阅读

来自骨髓增生性肿瘤患者的造血祖细胞的血小板生成素不依赖性巨核细胞分化

Chloe A. L. Thompson-Peach [...] Daniel Thomas

2023年01月20日 1302 阅读

Abstract

Pituitary adenomas are among the more frequent intracranial tumors usually treated with both surgical and pharmacological–based on somatostatin and dopamine agonists–approaches. Although mostly benign tumors, the occurrence of invasive behaviors is often detected resulting in poorer prognosis. The use of primary cultures from human pituitary adenomas represented a significant advancement in the knowledge of the mechanisms of their development and in the definition of the determinants of their pharmacological sensitivity. Moreover, recent studies identified also in pituitary adenomas putative tumor stem cells representing, according to the current hypothesis, the real cellular targets to eradicate most malignancies. In this protocol, we describe the procedure to establish primary cultures from human pituitary adenomas, and how to select, in vitro expand, and phenotypically characterize putative pituitary adenoma stem cells.

Keywords: Pituitary adenoma (垂体腺瘤)

Cancer stem cells (癌症干细胞)

Primary cultures (原代培养物)

Background

Pituitary adenomas are among the most common intracranial neoplasms (up to 15%) and cross-sectional studies have found a prevalence of around 90 cases per 100,000 inhabitants, with the vast majority being adults over 30 years old. Approximately 10% of unselected pituitaries examined at autopsy (i.e., considering also the pituitaries of subjects without previous diagnosis of pituitary disease) have developed adenomas (Molitch, 2017). Although often benign tumors, the management of pituitary adenomas can be complicated by the clinical syndromes related to hormone hypersecretion, or by the development of aggressive behavior characterized by resistance to treatment, high proliferation rate, rapid recurrence and extrasellar invasion (Carreno et al., 2017). The persistence of stem cells in adult pituitary (Florio, 2011) led to the hypothesis that the development of pituitary adenomas (and possibly of other benign neoplasia) can derive from subpopulations of tumor cells endowed with stem cell properties (mainly self-renewal and differentiation ability), as already established for malignant solid and hematologic tumors.

Recently experimental evidence showed that cancer stem cells (CSC) paradigm also applies to human and mouse pituitary adenomas (Donangelo et al., 2014; Peverelli et al., 2017; Wurth et al., 2017), and it was proposed that oncogenically-transformed CSCs can originate the tumor, clonally. The concept of CSC as tumor-initiating cells (TICs), initially developed for malignant neoplasia, proposes that only a subset of tumor cells, the CSC subpopulations, is responsible of initiating and maintaining tumor growth, causing invasiveness and the formation of metastasis, and conferring drug resistance (Clevers, 2011; Florio and Barbieri, 2012). This theory, leading to a cell hierarchy within a given tumor, replaced the stochastic model of cancerogenesis that proposed the bulk of solid tumors to be composed of cells showing equal tumorigenic potential. A more recent evolution of the CSC model is the ‘dynamic-stemness’ theory, which postulates an interchange between CSCs and more-differentiated (progenitors) cells, determined by epigenetic and microenvironmental signals, transcription factors, miRNAs or the activation of oncogenic pathways (Li and Laterra, 2012).

Besides the relevance from a theoretical point of view, the identification of putative CSCs in pituitary adenomas could represent the basis to identify possible novel pharmacological targets to treat pituitary adenomas, in particular for the more aggressive and poorly responsive subtypes.

Primary cultures from human pituitary adenomas have been used since long to study genetic and pharmacological features of these cells, but the definition of the presence of CSCs within pituitary adenomas raises the issue of their identification and isolation within a non-selected culture, and expansion in vitro to allow genetic, biological and pharmacological studies.

In this protocol, we describe the procedures to establish primary cultures from human pituitary adenomas and to select and expand in vitro putative CSCs (Wurth et al., 2017). Experimental data from their characterization are also reported.

Materials and Reagents

Aluminum foils (Cogepack, catalog number: 30060A )
Petri dishes 60 mm (Eppendorf, catalog number: 0030701119 )
Sterile mono-use scalpel (Paramount Surgimed)
15 ml centrifuge tubes (EUROCLONE, catalog number: ET5015B )
50 ml centrifuge tubes (EUROCLONE, catalog number: ET5050B )
100 µm cell strainer (Corning, Falcon^®, catalog number: 352360 )
24-well plates (Eppendorf, catalog number: 0030722116 )
T-25 culture flask (Eppendorf, catalog number: 0030710029 )
Sterile tips
10 μl PCR clean/sterile (Eppendorf, catalog number: 022491202 )
200 μl PCR clean/sterile (Eppendorf, catalog number: 022491296 )
1,000 μl PCR clean/sterile (Eppendorf, catalog number: 0030077857 )
Autoclave indicator tape (Arintha Biotech, catalog number: TS1950 )
LS Columns (Miltenyi Biotec, catalog number: 130-042-401 )
8-well Chamber slides (Corning, Falcon^®, catalog number: 354118 )
Coverslip (Menzel-Gläser)
pH paper
Membrane filter 0.45 µm (Merck, catalog number: HAWP04700 )
Sterile phosphate buffered saline (PBS) (EUROCLONE, catalog number: ECB4004L )
70% ethanol
Immune-magnetic sorting (Miltenyi Biotec, catalog number: 130-097-049 )
Ammonium-Chloride-Potassium (ACK) Lysing Buffer (Lonza, catalog number: 10-548E )
Anti-Fibroblast MicroBeads, human (Miltenyi Biotec, catalog number: 130-050-601 )
Normal Goat Serum (NGS) (Sigma-Aldrich, catalog number: G9023 )
CD133 MicroBead Kit–Tumor Tissue, human (Miltenyi Biotec, catalog number: 130-100-857 )
CD133, polyclonal rabbit (Abcam, catalog number: ab28364 )
Notch1 monoclonal mouse (Abcam, catalog number: ab44986 )
CXCR4 monoclonal mouse (R&D Systems, catalog number: MAB21651 )
Oct4, polyclonal rabbit (Abcam, catalog number: ab19857 )
Nestin, polyclonal rabbit (Abcam, catalog number: ab22035 )
D2R, monoclonal mouse (Santa Cruz Biotechnologies, catalog number: sc-5303 )
SSTR2A, polyclonal rabbit (Gramsch Laboratories, catalog number: SS-800 )
AlexaFluor 2^nd antibody (488 and 568: Thermo Fisher Scientific, Invitrogen, catalog numbers: A-11008 and A-11004 )
DAPI (Sigma-Aldrich, catalog number: D9542 )
TrypLE-express dissociation reagent (Thermo Fisher Scientific, Gibco^TM, catalog number: 12605 )
0.4% trypan blue solution (Bio-Rad Laboratories, catalog number: 145-0013 )
Bovine serum albumin (BSA) heat shock fraction, pH 7, ≥ 98% (Sigma-Aldrich, catalog number: A7906 )
EDTA (CARLO ERBA Reagents, catalog number: 405497 )
Minimum essential medium (MEM)/HAM’S F12 (1:1, EUROCLONE, catalog numbers: ECB2071L and ECB7502L )
Fetal bovine serum (FBS, Thermo Fisher Scientific, Gibco^TM, catalog number: 10270098 )
L-glutamine (EUROCLONE, catalog number: BE17-605E )
Penicillin-streptomycin (EUROCLONE, catalog number: ECB3001D )
B27 (50x, Thermo Fisher Scientific, Gibco^TM, catalog number: 17504044 )
Leukemia inhibitory factor (LIF, Sigma-Aldrich, catalog number: L5283 )
bFGF (Miltenyi Biotec, catalog number: 130-093-838 )
EGF (Miltenyi Biotec, catalog number: 130-093-825 )
Paraformaldehyde (Thermo Fisher Scientific, Thermo Scientific^TM, catalog number: 28908 )
Sodium hydroxide (NaOH) (Sigma-Aldrich, catalog number: 71687 )
Glycine (AppliChem, catalog number: A3707 )
Triton X-100 (VWR, catalog number: 437002A )
Glycerol (Sigma-Aldrich, catalog number: 77067 )
Mowiol (Merck, catalog number: 475904 )
Tris buffer (pH 8.5)
Buffer for magnetic cell separator (see Recipes)
Pituitary adenoma stem cell medium (see Recipes)
Standard pituitary adenoma cell medium (see Recipes)
Formaldehyde solution (see Recipes)
100 mM glycine (see Recipes)
0.1% Triton X-100 (see Recipes)
Mowiol solution (see Recipes)

Equipment

Surgical scissors and forceps (Exacta Optech, catalog numbers: 6.236 264 and 9.204 222 )
Autoclave
Pipettes (10, 200, and 1,000 μl, Eppendorf, catalog numbers: 3123000020 , 3123000055 , and 3123000063 )
Tissue culture hood (Euroclone, BIOAIR, model: TopSafe 1.8m Class II )
Water bath (GFL, catalog number: 1083 )
Centrifuge (Eppendorf, models: 5810 R and 5427 R )
CO₂ incubator (Thermo Fisher Scientific, Thermo Scientific^TM, model: 3111 )
Light microscope (Leica, model: Leica DMIL HC TYPE 090-135.001 )
MidiMACS^TM Separator (Miltenyi Biotec, catalog number: 130-042-302 ) attached to a MultiStand (Miltenyi Biotec, catalog number: 130-042-303 )
Cell counter (Bio-Rad Laboratories, model: TC20^TM )

Software

Statistic software (i.e., PRISM, GraPhad or similar)
ImageJ

Procedure

English

中文翻译

文章信息

版权信息

如何引用

Würth, R., Pattarozzi, A., Barbieri, F. and Florio, T. (2018). Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas. Bio-protocol 8(7): e2790. DOI: 10.21769/BioProtoc.2790.